188 related articles for article (PubMed ID: 22024541)
1. Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.
Suh EJ; Kabir MH; Kang UB; Lee JW; Yu J; Noh DY; Lee C
Exp Mol Med; 2012 Jan; 44(1):36-44. PubMed ID: 22024541
[TBL] [Abstract][Full Text] [Related]
2. Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.
Kang UB; Ahn Y; Lee JW; Kim YH; Kim J; Yu MH; Noh DY; Lee C
BMC Cancer; 2010 Mar; 10():114. PubMed ID: 20346108
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
4. Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness.
Procházková I; Lenčo J; Fučíková A; Dresler J; Čápková L; Hrstka R; Nenutil R; Bouchal P
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):488-498. PubMed ID: 28216224
[TBL] [Abstract][Full Text] [Related]
5. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
Zhang F; Chen JY
BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
[TBL] [Abstract][Full Text] [Related]
6. Discovery and validation of breast cancer early detection biomarkers in preclinical samples.
Li CI
Horm Cancer; 2011 Apr; 2(2):125-31. PubMed ID: 21761335
[TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.
Cabezón T; Gromova I; Gromov P; Serizawa R; Timmermans Wielenga V; Kroman N; Celis JE; Moreira JM
Mol Cell Proteomics; 2013 Feb; 12(2):381-94. PubMed ID: 23172894
[TBL] [Abstract][Full Text] [Related]
8. Serum Dickkopf-1 acts as a new biomarker in human breast cancer.
Liu JT; Guo WB; Sun JY
Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066
[TBL] [Abstract][Full Text] [Related]
9. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
Chen C; Chen Q; Dong Y; Liu X
Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
[TBL] [Abstract][Full Text] [Related]
11. A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy.
Lasham A; Fitzgerald SJ; Knowlton N; Robb T; Tsai P; Black MA; Williams L; Mehta SY; Harris G; Shelling AN; Blenkiron C; Print CG
Clin Breast Cancer; 2020 Apr; 20(2):108-116. PubMed ID: 31607655
[TBL] [Abstract][Full Text] [Related]
12. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies.
Steuber T; Tennstedt P; Macagno A; Athanasiou A; Wittig A; Huber R; Golding B; Schiess R; Gillessen S
BJU Int; 2019 May; 123(5):826-833. PubMed ID: 30216634
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
Gromov P; Gromova I; Bunkenborg J; Cabezon T; Moreira JM; Timmermans-Wielenga V; Roepstorff P; Rank F; Celis JE
Mol Oncol; 2010 Feb; 4(1):65-89. PubMed ID: 20005186
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
17. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of serum MACC1 in breast cancer patients.
Tan W; Xie X; Li L; Tang H; Ye X; Chen L; Tang W; Gao J; Pan L; Zhang X; Ye F; Li X; Yang L; Xie X; Zheng W
Oncotarget; 2016 Dec; 7(51):84408-84415. PubMed ID: 27793048
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
[TBL] [Abstract][Full Text] [Related]
20. Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.
Buas MF; Rho JH; Chai X; Zhang Y; Lampe PD; Li CI
Breast Cancer Res Treat; 2015 Sep; 153(2):445-54. PubMed ID: 26319120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]